HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges-Reference-Cited by-同舟云学术

HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges

Published:2015-12 Issue: Volume:36 Page:210-216
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Villabona-Arenas Christian Julian,Domyeum Jenny,Mouacha Fatima,Butel Christelle,Delaporte Eric,Peeters Martine,Mpoudi-Ngole Eitel,Aghokeng Avelin Fobang

Funder

IRD

National Institutes of Health

Agence Nationale de Recherches sur le SIDA, France

Labex EpiGenMed

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference39 articles.

1. Widely varying SIV prevalence rates in naturally infected primate species from Cameroon;Aghokeng;Virology,2006

2. Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon;Aghokeng;PLoS One,2009

3. Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon;Aghokeng;AIDS Res. Hum. Retrovir.,2013

4. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates;Arien;J. Virol.,2005

5. HIV-1 group O infection in Cameroon, 1986 to 1998;Ayouba;Emerg. Infect. Dis.,2001

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Origin and Emergence of HIV/AIDS;Genetics and Evolution of Infectious Diseases;2024

2. HIV-1 Non-Group M Strains and ART;Viruses;2023-03-17

3. Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches;Journal of Antimicrobial Chemotherapy;2022-04-30

4. HIV Genetic Diversity, Virological Failure, and Drug Resistance in Libreville, Capital of Gabon, before a Total Dolutegravir-Based Regimen Transition;World Journal of AIDS;2022

5. Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants;JAIDS Journal of Acquired Immune Deficiency Syndromes;2021-10-01